Our Solutions   Erlotero 100 mg Tablets

Erlotero 100 mg Tablets

Erlotero 100Mg Tablet

*To be consumed as directed by physician.

Therapies:

Anti Neoplastics

Composition:

Erlotinib Hydrochloride IP equivalent to Erlotinib 100 mg

About Erlotero 100Mg Tablet

Erlotero 100 mg Tablets contains Erlotinib 100 mg, a targeted anticancer medicine belonging to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor class. It is prescribed for the treatment of EGFR-positive non-small cell lung cancer (NSCLC) and, in combination with other medicines, pancreatic cancer, as advised by an oncologist. Erlotinib works by blocking EGFR signaling pathways that promote the growth and spread of cancer cells, thereby slowing disease progression. Erlotero should be used only under the supervision of a qualified oncology specialist.

Erlotero 100Mg Tablet

*To be consumed as directed by physician.


Usage Instructions

  • Take Erlotero 100 mg Tablets exactly as prescribed by your doctor.
  • It should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal, preferably at the same time each day.
  • Continue treatment for as long as recommended by your oncologist.
  • Do not change the dose or stop taking the medicine without medical advice, even if you begin to feel better.
  • Regular monitoring of liver function and overall health may be required throughout treatment.

    • Benefits and Use

  • Erlotero 100 mg Tablets is indicated for the treatment of EGFR-positive non-small cell lung cancer that is locally advanced or has spread to other parts of the body, and in selected cases of pancreatic cancer in combination with other anticancer medicines.
  • By specifically blocking EGFR-mediated signaling, Erlotinib slows the growth and multiplication of cancer cells, helping delay disease progression and improve treatment outcomes.
  • When used under specialist supervision, it forms an important part of targeted cancer therapy.

    • Safety Information

  • Pregnancy:
  • Erlotero should not be used during pregnancy unless the potential benefit clearly outweighs the risk. Effective contraception should be used by both men and women during treatment and for at least one month after the last dose.
  • Breastfeeding:
  • Breastfeeding is not recommended during treatment and for a period advised by your doctor after stopping therapy.
  • Alcohol:
  • Consult your doctor before consuming alcohol during treatment.
  • Smoking:
  • Avoid smoking, as it can significantly reduce the effectiveness of Erlotinib and may require dose adjustment.
  • Kidney Disorders:
  • Use with caution in patients with kidney impairment. It is generally not recommended in severe kidney disease without specialist advice.
  • Liver Disorders:
  • Patients with liver disease require careful monitoring, and dose adjustment may be necessary.
  • Sun Exposure:
  • Erlotinib may increase sensitivity to sunlight; wear protective clothing and use sunscreen when outdoors.
  • Driving:
  • If you experience dizziness, vision changes, or fatigue, avoid driving or operating machinery.
  • Seek immediate medical attention if you develop severe diarrhea, persistent cough, shortness of breath, mouth ulcers, or vision changes.
  • Inform your doctor about all medicines you are taking, especially acid-reducing medications, as they may interact with Erlotinib.

    • Ingredients

    Erlotinib Hydrochloride IP equivalent to Erlotinib 100 mg

    How to Use

  • Swallow one Erlotero 100 mg Tablets whole with water on an empty stomach.
  • Do not crush, chew, or break the tablet.
  • Avoid taking antacids, H2 blockers (such as ranitidine), or other acid-reducing medicines close to the dose, unless advised by your doctor, as they may reduce the absorption of Erlotinib.
  • Maintain adequate hydration during treatment and follow all instructions provided by your healthcare team.

    • Storage Information

    Store below 30°C in a cool, dry place, protected from moisture, heat, and direct sunlight.